
Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
ValueMarkers Composite Index
DCF data not available
Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS) — VMCI valuation read
The headline on Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS) is a 47/100 VMCI score, set against a Consumer Defensive sector median of 50. That 4-point below-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value drag is in the data.
603363.SS insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.
**Investor frame.** 603363.SS trades at 15.0x earnings, 17% below the Consumer Defensive median of 18.0x sets the value side. ROIC of 11.0% sits 1.0pp above the Consumer Defensive median (10.0%) sets the quality side. Net debt to EBITDA of -0.9x leaves covenant headroom sets the risk side, the three lines a value buyer reads first on 603363.SS.
603363.SS rose 1.6% over the trailing 7 days, with a -3.7% read on a 30-day basis.
Fujian Aonong Biological Technology Group Incorporation Limited engages in the feed, pig raising, raw materials trade, agricultural internet, bio-pharmaceutical, and other businesses in China and internationally. The company researches and develops, produces, and sells feed products, such as pig feed, poultry feed, aquatic feed, ruminant feed, and other products; operates pig breeding farms; and engages in the pig slaughtering and processing activities. It also provides vaccines, veterinary drug preparations, micro ecological preparations, powders, premixes, oral liquids, additives, disinfectants, and other products, as well as creates intelligent breeding service platform. The company was founded in 2011 and is based in Xiamen, China.
Related Stocks in Consumer Defensive
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.